- Microbix Biosystems 341 Bering Ave Toronto Canada
- 001 416 234 1624
- 001 416 234 1626
27 October 2009 - Microbix has signed an agreement with the Hunan Biopharmaceutical Company for initial financing to construct Asia's largest influenza vaccine production facility.
Vaughn Embro-Pantalony has been appointed to the board of directors, replacing James A Long who has assumed his duties as chief financial officer, and has resigned as a director
Technology can separate male-producing sperm from female-producing sperm, thus ensuring the desired sex of offspring for use in commercial cattle and swine livestock production
Microbix enters exclusive review and negotiation period for proprietary influenza virus yield enhancement technology
New proprietary vaccine technology platform is said to have the potential to offer significant economic advantages to vaccine producers